Allylic isothiouronium salts: The discovery of a novel class of thiourea analogues with antitumor activity

Eur J Med Chem. 2017 Mar 31:129:151-158. doi: 10.1016/j.ejmech.2017.02.013. Epub 2017 Feb 12.

Abstract

A series of 28 aryl- and alkyl-substituted isothiouronium salts were readily synthesized in high yields through the reaction of allylic bromides with thiourea, N-monosubstituted thioureas or thiosemicarbazide. The S-allylic isothiouronium salts substituted with aliphatic groups were found to be the most effective against leukemia cells. These compounds combine high antitumor activity and low toxicity toward non-tumoral cells, with selectivity index higher than 20 in some cases. Furthermore, the selected isothiouronium salts induced G2/M cell cycle arrest and cell death, possibly by apoptosis. Therefore, these compounds can be considered as a promising class of antitumor agents due to the potent cytostatic activity associated with high selectivity.

Keywords: Allylic bromides; Antitumor activity; DNA fragmentation; Isothiouronium salts; Leukemia.

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology*
  • Cell Cycle Checkpoints / drug effects
  • Cell Death / drug effects
  • Humans
  • Isothiuronium / chemical synthesis*
  • Isothiuronium / pharmacology*
  • Structure-Activity Relationship
  • Thiourea / analogs & derivatives*

Substances

  • Antineoplastic Agents
  • Isothiuronium
  • Thiourea